Clay Thorp, Director at Clearside Biomedical, Inc. (CLSD), sold 65,746 shares at $4.43 ($291K) on 2021-02-10, disclosed to the SEC on 2021-02-12.
Open-market sale of $291k CLSD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.43 | 32,873 | $146K | 50.0% |
| 2 | $4.43 | 32,873 | $146K | 50.0% |
| Total | $4.43 avg | 65,746 | $291K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |